Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to -$1.4 million.

  • Myomo's Change in Accured Expenses fell 25120.71% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $897995.0, marking a year-over-year decrease of 4183.78%. This contributed to the annual value of $4.7 million for FY2024, which is 16216.64% up from last year.
  • Per Myomo's latest filing, its Change in Accured Expenses stood at -$1.4 million for Q3 2025, which was down 25120.71% from -$2.0 million recorded in Q2 2025.
  • Myomo's Change in Accured Expenses' 5-year high stood at $2.8 million during Q4 2024, with a 5-year trough of -$2.0 million in Q2 2025.
  • Moreover, its 5-year median value for Change in Accured Expenses was $386880.0 (2023), whereas its average is $262382.1.
  • Within the past 5 years, the most significant YoY rise in Myomo's Change in Accured Expenses was 155540.03% (2025), while the steepest drop was 31816.45% (2025).
  • Over the past 5 years, Myomo's Change in Accured Expenses (Quarter) stood at $535997.0 in 2021, then tumbled by 183.53% to -$447716.0 in 2022, then increased by 21.41% to -$351845.0 in 2023, then soared by 895.05% to $2.8 million in 2024, then crashed by 148.91% to -$1.4 million in 2025.
  • Its Change in Accured Expenses was -$1.4 million in Q3 2025, compared to -$2.0 million in Q2 2025 and $1.4 million in Q1 2025.